Contribution of Noncanonical Splice Variants to TTN Truncating Variant Cardiomyopathy.
Parth N PatelShefali S VermaJon A L WillcoxAlireza HaghighiMin Young JangJoshua M GorhamSteven R DePalmaLien LamBarbara McDonoughRenee JohnsonNeal K LakdawalaAmy E RobertsPaul J R BartonStuart Alexander CookDiane FatkinChristine E SeidmanJonathan G SeidmanPublished in: Circulation. Genomic and precision medicine (2021)
Noncanonical splice-altering variants in TTN explain 1-2% of DCM and offer a 10-20% increase in the diagnostic power of TTN sequencing in this disease. These data suggest rules that may improve efforts to detect splice-altering variants in other genes and may explain the low percent splicing observed for many alternate TTN exons.